₹13.15
▲ +0.65 +5.20%
As of 29 Jul 2026 · delayed
NSE Listed · Healthcare
Nidan Laboratories & Healthcare Ltd. (NIDAN)
Volume: 0Avg Vol 1W: 5,600Avg Vol 1M: 5,95552W Range:₹11.5₹24.9
Key Ratios
Checked 3h agoMarket Cap—
Current Price₹13.15
Previous Close₹12.5
High / Low (52w)₹24.9 / ₹11.5
Volume0
Avg Vol (1W)5,600
Avg Vol (1M)5,955
Stock P/E7.23
Book Value₹15.28
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value₹10
EPS (TTM)₹1.82
P/B0.86
Debt / Equity—
50 DMA₹13.74
200 DMA₹16.5
Day change+5.20%
Price Chart
₹13.15▼ 30.97% · 1Y
2025-07-292026-07-29
20-day avg volume: 6K shares
Pros
- Stock trades below its book value.
Quarterly Results
| Metric | Jun 2021 | Sept 2021 |
|---|---|---|
| Revenue | ₹8 Cr | ₹17 Cr |
| EBITDA | ₹2 Cr | ₹4 Cr |
| Net Profit | ₹1 Cr | ₹2 Cr |
| EPS | — | — |
Profit & Loss (Annual)
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹21 Cr | ₹22 Cr | ₹21 Cr | ₹30 Cr | ₹28 Cr | ₹27 Cr | ₹27 Cr |
| EBITDA | ₹5 Cr | ₹4 Cr | ₹7 Cr | ₹7 Cr | ₹7 Cr | ₹6 Cr | ₹5 Cr |
| Net Profit | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹3 Cr | ₹4 Cr | ₹-3 Cr | ₹2 Cr |
| EPS | 0.23 | 0.72 | 2.33 | 2.32 | 2.55 | -2.33 | 1.42 |
Balance Sheet
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Total Assets | ₹43 Cr | ₹45 Cr | ₹54 Cr | ₹88 Cr | ₹84 Cr | ₹83 Cr | ₹83 Cr |
| Total Liabilities | ₹33 Cr | ₹34 Cr | ₹40 Cr | ₹23 Cr | ₹15 Cr | ₹16 Cr | ₹15 Cr |
| Equity | ₹10 Cr | ₹11 Cr | ₹13 Cr | ₹66 Cr | ₹69 Cr | ₹66 Cr | ₹68 Cr |
| Total Debt | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹4 Cr | ₹9 Cr | ₹11 Cr | ₹8 Cr | ₹4 Cr |
| Investing | ₹-3 Cr | ₹-36 Cr | ₹0 Cr | ₹-11 Cr | ₹0 Cr |
| Financing | ₹-1 Cr | ₹29 Cr | ₹-10 Cr | ₹0 Cr | ₹-3 Cr |
| Free Cash Flow | ₹4 Cr | ₹9 Cr | ₹11 Cr | ₹8 Cr | ₹4 Cr |
Shareholding
Promoter 57.04% Institutions 0% Public 42.96%
Efficiency & Working Capital
ROCE6.2%
Interest Coverage2.3
Dividend Payout—
Debtor Days19 d
Inventory Days8 d
Payable Days14 d
Cash Conversion Cycle13 d
Working Capital Days27 d
Shareholding Details
As of 2026-06-30
Promoter57%
FII0%
DII0%
Institutions0%
Public43%
Promoter Pledge0%
No. of Shareholders2,359
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Nov 2021 | Mar 2022 | Sept 2022 | Mar 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 71.2% | 71.2% | 71.2% | 71.2% | 62.8% | 57% | 57% | 57% | 57% | 57% | 57% | 57% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 28.8% | 28.8% | 28.8% | 28.8% | 37.2% | 43% | 43% | 43% | 43% | 43% | 43% | 43% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 2,940 | 2,791 | 2,516 | 2,440 | 2,777 | 2,864 | 2,790 | 2,581 | 2,489 | 2,437 | 2,362 | 2,359 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Nitin Vitthalrao Thorve | Shareholding of Promoter and Promoter Group | 50.2% | 69,70,500 |
| Roshan Nitin Thorve | Shareholding of Promoter and Promoter Group | 6.9% | 9,57,200 |
| Ramegowda Sonnenahalli Omprakash Gowda | Public Shareholding | 1.1% | 1,55,000 |
| Devendra Rajnikant Ladhani | Public Shareholding | 1.1% | 1,50,000 |
| Lata Vitthal Hande | Shareholding of Promoter and Promoter Group | 0% | 100 |
| Krupesh Deepak Thakur | Shareholding of Promoter and Promoter Group | 0% | 100 |
| Edwin Francis Dabre | Shareholding of Promoter and Promoter Group | 0% | 100 |
| Tejal Anil Jayakar | Shareholding of Promoter and Promoter Group | 0% | 100 |
| Vitthal Laxman Thorave | Shareholding of Promoter and Promoter Group | 0% | 100 |
| Abhilasha Nitin Thorave | Shareholding of Promoter and Promoter Group | 0% | 100 |
| Hariprit Nitin Thorave | Shareholding of Promoter and Promoter Group | 0% | 100 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Abhinay Shashikant Nerurkar | Independent Non Exe. Director | 2025 |
| Nilesh Ghanshyam Bhide | Independent Non Exe. Director | 2025 |
| Abhijeet Dhanegaonkar | Independent Non Exe. Director | 2025 |
| Edwin Francis Dabre | Executive Non Independent Dir. | 2025 |
| Tejal Anil Jayakar | Non Independent Executive Director / CFO | 2025 |
| Krupesh Deepak Thakur | Non-Exec & Non-Independent Dir | 2025 |
| Varsha Maniar | Company Sec. & Compli. Officer | 2025 |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| India | ₹25 Cr | 100% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 50 | 14 | 14 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 1 | 50 | 51 |
| 2025 | 0 | 0 | 0 | 0 | 48 | 49 |
| 2025 | 0 | 0 | 0 | 0 | 1 | 1 |
Company Information
🌐 www.nidanhealthcare.co.in ↗
📍 Swapnshilpa Behind Aarti Apart, Vatak Road Virar (West), Palagar, Maharashtra, 401303
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search